LGNXZ
Ligand Pharms Glucagon
Save
4.02B
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M.
Similar securities
Based on sector and market capitalization
Report issue